Gut and Liver · 2022 · 17 citations · 46 references
MedicineMolecular BiologyOncologyApoptosisCell SignalingMolecular OncologyCancer Cell SignalingCancer ProgressionColorectal CancerIntegrin SignalingMetastatic Signaling PathwaysOncogenic Signaling PathwaysCancer Cell ApoptosisCancer Signaling PathwaysColorectal Carcinogenesis PathophysiologyIntegrin Signaling In CancerMolecular Mechanisms Of CarcinogenesisOncogenic Transformation
Background/Aims: This study aimed to investigate the biological function and regulatory mechanism of TCN1 in colorectal cancer (CRC). Methods: . Results: TCN1 knockdown attenuated CRC cell proliferation and invasion and promoted cell apoptosis. Overexpression of TCN1 yielded the opposite effects. In addition, TCN1-knockdown HCT116 cells failed to form metastatic foci in the peritoneum after intravenous injection. Molecular mechanism analyses showed that TCN1 interacted with integrin subunit β4 (ITGB4) to positively regulate the expression of ITGB4. TCN1 knockdown promoted the degradation of ITGB4 and increased the instability of ITGB4 and filamin A. Downregulation of ITGB4 at the protein level resulted in the disassociation of the ITGB4/plectin complex, leading to cytoskeletal damage. Conclusions: TCN1 might play an oncogenic role in CRC by regulating the ITGB4 signaling pathway.
46
Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 18K citations · Full text
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker et al. · The Lancet Oncology · 2014 · 1.7K citations
Medicine, Oncology, Pharmacology +9
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics
Tsan Sam Xiao, Junichi Takagi, Barry S. Coller et al. · Nature · 2004 · 842 citations